Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

AstraZeneca is pushing the boundaries of science to create life-changing medicines that aim to reduce the global burden and complications of diabetes. Driven to redefine outcomes for people with diabetes, AstraZeneca's current portfolio comprises the newest classes of treatments that support individualised approaches to diabetes care. As a core strategic area the company is focusing its research and development efforts in diverse populations and patients with significant co-morbidities.
Característiques principals
The primary goal of the project is to develop novel evidence-based approaches for the patient-centred management of type 2 diabetes, based on a validated algorithm to be assessed in a “real world” setting. This approach will be used to identify targets including, but not necessarily limited to, glycaemia and to provide guidance to drug selection/combination towards the overall long-term goals.

In order to achieve the primary goal, the project may include but not necessarily be restricted to the following objectives:
  • Involvement of diabetes stakeholders (clinical investigators, primary care physicians, diabetes nurses, patients, etc) and their representative non-profit organisations
  • Development of novel electronic registry and clinical data collection/management
  • Definition of parameters of interest and assessment of their relative weight with respect to clinical decision making
  • Algorithm development and validation (i.e. in silico, clinical follow up; historical comparison or parallel arm evaluations; outcomes…)
  • App development and integration technology (for example cloud technology with the purpose of regular patient monitoring and automatic flag generation for deviation from targets) and relative validation in “real-life” clinical settings
  • Implementation and evaluation of innovative approaches for patient empowerment through education
  • Development of novel organisational models for holistic clinical management of type 2 diabetes
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.1670
    Convocatòria (URL)
    http://www.europeandiabetesfoundation.org/index.php/ct-menu-item-5/14-sample-data-articles/243-efsd-az-pact
    Requisits
    Tenders are invited from single non-profit institutions/organisations or groups of such entities from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
    Dotació
    Not to exceed 500,000 Euros
    Durada
    3 years

    Arxius

    Arxiu
    Application Form